Recurrence of head and neck cancer after surgery or irradiation: Prospective comparison of 2-deoxy-2-[F-18]fluoro-D-glucose PET and MR imaging diagnoses

Radiology

Volumn 200, Issue 1, 1996, Pages 135-141

  Anzai, Yoshimi ^a   Carroll, William R ^a   Quint, Douglas J ^a   Bradford, Carol R ^a   Minoshima, Satoshi ^b   Wolf, Gregory T ^a   Wahl, Richard L ^a,b  

^a UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Emission CT (ECT), comparative studies; Gadolinium; Head and neck neoplasms, CT; Head and neck neoplasms, emission CT (ECT); Head and neck neoplasms, MR

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CLINICAL ARTICLE; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FEMALE; HEAD AND NECK CANCER; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 0029936104     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.200.1.8657901     Document Type: Article

References (30)

1. Silverberg E. Cancer Statistics, 1982. CA Cancer J Clin 1982; 32:15-31.
2. Million RR, Cassisi NJ. Oral cavity. In: Million RR, Cassisi NJ, eds. Management of head and neck cancer: a multidisciplinary approach. 2nd ed. Philadelphia, Pa: Lippincott, 1994; 239-298.
3. Mukherji SK, Mancuso AA, Kotzur IM, et al. Radiologic appearance of irradiated larynx. II. Primary site response. Radiology 1994; 193:149-154.
4. Glazer HS, Niemeyer JH, Baalfe DM, et al. Neck neoplasm: MR imaging. II. Post-treatment evaluation. Radiology 1986; 160:349-354.
5. Gussack GS, Hudgin PA. Imaging modalities in recurrent head and neck tumors. Laryngoscope 1991; 101:119-124.
6. Hudgins PA, Burson JG, Guack GS, Grist WJ. CT and MR appearance of recurrent malignant head and neck neoplasm after resection and flap reconstruction. AJNR 1994; 15:1689-1694.
7. Som PM, Biller HF. Computed tomography of the neck in the postoperative patient: radical neck dissection and the myocutaneous flap. Radiology 1983; 148:157-160.
8. Brown DH, Rhys-Evans PH, Cooke J. The use of computed tomography in assessing oral cancer recurrence after flap reconstruction. Am J Otolaryngol 1989; 10:161-164.
9. Ohgi K, Kohno A, Itabashi K, et al. Head and neck reconstruction with pectoralis major myocutaneous flap: CT evaluation. J Comput Assist Tomogr 1990; 14:286-290.
10. Di Chiro G, De la Paz RL, Brooks RA, et al. Glucose utilization of cerebral gliomas measured by 18F-fluorodeoxyglucose and PET. Neurology 1982; 32:1323-1329.
11. Haberkorn U, Strauss LG, Reisser C, et al. Glucose uptake, perfusion, and cell proliferation in head and neck tumors: relationship of positron emission tomography to flow cytometry. J Nucl Med 1991; 32:1548-1555.
12. Haberkorn U, Strauss LG, Dinitrakopoulouo A, et al. Fluorodeoxyglucose imaging of advanced head and neck cancer after chemotherapy. J Nucl Med 1993; 34:12-17.
13. Rege SD, Chailen L, Hoh CK, et al. Changes induced by radiation therapy in FDG uptake in normal and malignant structures of the head and neck: quantitation with PET. Radiology 1993; 189:807-812.
14. Jabour BA, Choi Y, Hoh CK, et al. Extracranial head and neck: PET imaging with 2-[F-18] fluoro-2-deoxy-D-glucose and MR imaging correlation. Radiology 1993; 186: 27-35.
15. Reisser C, Haberkorn U, Strauss LG. The relevance of positron emission tomography for the diagnosis and treatment of head and neck tumors. J Otolaryngol 1993; 22: 231-238.
16. Rege S, Maass A, Chaiken L, et al. Use of positron emission tomography with fluorodeoxyglucose in patients with extracranial head and neck cancers. Cancer 1994; 73: 3047-3058.
17. Greven KE, Williams DW III, Keyes JW Jr, et al. Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation. Cancer 1994; 74:1355-1359.
18. Chaiken L, Rege S, Hoh C, et al. Positron emission tomography with fluorodeoxy-glucose to evaluate tumor response and control after radiation therapy. Int J Radiat Oncol Biol Phys 1993; 27:455-464.
19. Berlangieri SU, Brizel DM, Scher RL, Schifter T, Hawk TC, Hamblen S. Pilot study of positron emission tomography in patients with advanced head and neck cancer receiving radiotherapy and chemotherapy. Head Neck 1994; 16:340-346.
20. Graven KM, Williams DW, Keyes JW, et al. Distinguishing tumor recurrence from irradiation sequelae with positron emission tomography in patients treated for laryngeal cancer. Int J Radiat Oncol Biol Phys 1994; 29:841-845.
21. Bailet JW, Sercarz JA, Abemayor E, Anzai Y, Lufkin R, Hoh CK. The use of positron emission tomography for early detection of recurrent head and neck squamous cell carcinoma in post-radiotherapy patients. Laryngoscope 1995; 105:135-139.
22. Lapela M, Grenman R, Kurki T, et al. Head and neck cancer: detection of recurrence with PET and 2-[F-18] Fluoro-2-deoxyD-glucose. Radiology 1995; 197:205-211.
23. Zasadny KR, Wahl RL. Standardized uptake values of normal tissues at PET with 2-[fluorine-18J-fluoro-2-deoxy-D-glucose: variations with body weight and a method for correction. Radiology 1993; 189:847-850.
24. Metz CE, Wang PL, Kronman HB. A new approach for testing the significance of differences between ROC curves measured from correlated data. In: Deconinck F, ed. Information processing in medical imaging. The Hague, The Netherlands: Martinus Nijhoff, 1984:432-445.
25. Metz CE. ROC methodology in radiology imaging. Invest Radiol 1986; 21:720-733.
26. Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-deoxy-D-glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993; 34:773-779.
27. Levin DN, Hu X, Tan KK, et al. The brain: integrated three-dimensional display of MR and PET images. Radiology 1989; 172. 783-789.
28. Pelizzari CA, Chen GT, Spelbrng DR, et al. Accurate three-dimensional registration of CT, PET, and/or MR images of the brain. J Comput Assist Tomogr 1989; 13:20-26.
29. Levin DN, Pelizzari CA, Chen GT, et al. Retrospective geometric correlation of MR, CT, and PET images. Radiology 1988, 169: 817-823.
30. Wahl RL, Quint LE, Cieslak RD, Aisen AM, Koeppe RA, Meyer CR. "Anatometabolic" tumor imaging: fusion of FDG PET with CT or MRI to localize foci of increased activity. J Nucl Med 1993; 34:1190-1197.